Skip to main content
Premium Trial:

Request an Annual Quote

UCLA Installs HistoRx's Imaging-Analysis Tool in Biomarker Lab

NEW YORK (GenomeWeb News) — Biomarker profiling company HistoRx said yesterday that the University of California at Los Angeles has installed its image-analysis tool.
The New Haven, Conn.-based company said UCLA will use the PM-2000 system at its Biomarker Innovation Laboratory to develop in situ diagnostic assays.
Financial terms of the deal were not disclosed.
The PM-2000 employs HistoRx’s automated quantitative analysis technology to measure protein biomarkers in tissue and in tissue microarrays.
The company said the technology was developed at Yale University’s medical school and is being used through a corporate/academic research program at nine cancer and pathology research centers.
Yale researcher David Rimm, who developed the quantitative analysis technology, co-founded HistoRx and also serves as the company’s chief of medical affairs.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.